 |
인쇄하기
취소
|
Handok, Genexine joins forces in novel human growth hormone
Handok Pharmaceutical and Genexine, a drug development biotech, have agreed to join hands to develop Generxine’s next-generation human growth hormone.
Under the deal, both companies will make efforts to commercialize 'GX-H9' for foreign markets which is under preclinical trial in Europe.
GX-H9 is designed to supply patients with growth hormone using Genexine’s own hybrid Fc technology (an...
Under the deal, both companies will make efforts to commercialize 'GX-H9' for foreign markets which is under preclinical trial in Europe.
GX-H9 is designed to supply patients with growth hormone using Genexine’s own hybrid Fc technology (an...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.